Company / Share Buybacks
Corcept Therapeutics Incorporated Share Buybacks History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$172.9M
FY2025
5-year range
$0 / $172.9M
FY2021-FY2025
Trend
+1003.9%
vs FY2024
Sector context
#14 of 48
Health Care
What the data says
Share Buybacks changed +1004% YoY in FY2025, a notable deviation from the 2-year average annual change of +452%.
Based on SEC 10-K filings.
$173M in FY2025 with a 5-year CAGR of +48.9%.
Improved from $0 to $173M over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +48.9%
- 10-Year CAGR
- -
Sector benchmark
#14 of 48 in Health CareTop 29% of 48This company $172.9M Sector average $611.9M
▼
-71.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +48.9%, indicating consistent growth.
- In FY2025, share buybacks increased 1003.9% year-over-year.
- Ranks #14 out of 48 companies in the Health Care sector.
- Lowest share buybacks in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $172.9M | +1003.9% |
| FY2024 | $15.7M | - |
| FY2023 | $0 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $23.7M | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026